Level A· Stronger Clinical EvidenceMeta-analysisEurope PMCOpen access

Efficacy and safety of single versus repeated injections of mesenchymal stem cells for the treatment of knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials

Deng L., Zhao C., Zhou L., Mu X., Sun H., Li L.

Meta-analysis with a reported sample of 622 on Knee Osteoarthritis, Osteoarthritis, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.

Open my reading list
Level A· Stronger Clinical EvidenceEvidence level of this study

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Meta-analysis
Journal
Stem Cell Res Ther (2025)
Reported sample size
622
Source database
Europe PMC
PMID
41013772
PMCID
PMC12465953
DOI
10.1186/s13287-025-04638-2

Abstract (original English)

Background In recent years, mesenchymal stem cells (MSCs) have been widely applied in the clinical treatment of knee osteoarthritis (KOA), demonstrating promising therapeutic efficacy. However, intervention protocols for MSCs have not yet been standardized, and evidence regarding the impact of different injection frequencies on the efficacy and safety of MSC treatment in KOA remains limited. Objective This study aims to integrate evidence from conventional and network meta-analyses to evaluate the efficacy and safety of different intervention frequencies (single vs. repeated MSC injections) in the treatment of knee osteoarthritis (KOA). Methods A systematic search was conducted in PubMed, Embase, the Cochrane Library, and Web of Science databases up to March 1, 2025. Traditional meta-analysis was performed to assess the efficacy and safety of MSC therapy for KOA, followed by a network meta-analysis (NMA) to evaluate the effectiveness of single versus repeated MSC injections. Outcome measures included WOMAC and VAS scores at 3, 6, and 12 months, as well as the incidence of adverse events (AEs). Traditional meta-analysis and NMA were conducted using Review Manager 5.3 and Stata SE16.0, respectively. Results A total of 16 RCTs involving 622 patients were included. Traditional meta-analysis showed that MSC therapy significantly improved pain and knee joint function in KOA patients

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Relatively higher-quality human studies compared with other topics in this database, e.g. multiple RCTs or systematic reviews. This does not mean it is standard or approved care.

How we grade evidence
Mesenchymal Stem CellsHumansOsteoarthritis, KneeTreatment OutcomeMesenchymal Stem Cell TransplantationRandomized Controlled Trials as Topic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research